IL33 and Alzheimer disease: In the present study, PD0325901 treatment of the AD-like skin lesions in HrasG12S/+ mice was found to reverse these lesions by reducing hyperproliferation of p-ERK-positive epidermal cells and the production of inflammatory cells and cytokines, including IL-1β, IL-4, and IL-33.